ACUR Financial Facts

Research and development: 841K
Income tax expense: 0
See Full Income Statement

Accumulated deficit: -376.23M
Additional paid-in capital: 375.63M
See Full Balance Sheet

Acura Pharmaceuticals, Inc. (ACUR) Earnings

  |   Expand Research on ACUR
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -73.7% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -5.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/18/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
11/11/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
8/26/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/20/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
5/27/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
5/21/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
2/28/24 Q423 N/AN/A N/A N/AN/A N/A N/A N/A
11/13/23 Q323 N/AN/A N/A N/AN/A N/A N/A N/A